Diet and Diet-Related Factors in the PCPT
PCPT 中的饮食和饮食相关因素
基本信息
- 批准号:7102927
- 负责人:
- 金额:$ 25.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:antioxidantsbiopsycancer preventioncancer riskcell transformationclinical researchclinical trialsdietary constituentfatty acidsfinasteridegene mutationhormone metabolismhuman datalifestylelongitudinal human studyneoplasm /cancer epidemiologynutrient drug interactionnutrient interactionnutrition related tagoxidative stressphospholipidsprostate neoplasmssteroid hormone
项目摘要
DESCRIPTION (provided by applicant): This revised study proposes to examine whether a broad
range of dietary and diet-related lifestyle factors affect prostate cancer risk, and is organized around two mechanisms that could mediate effects of diet on prostate carcinogenesis: stimulation of cell growth by steroid hormones, insulin and insulin-like growth factors; and accumulation of somatic mutations caused by oxidative damage. Significant modifications in this revised proposal include more detailed and hypothesis-driven Cross-Project Aims, more accurate estimates of sample sizes, and completion of pilot studies on obesity and glycemic index. Using comprehensive data from the PCPT on diet-related exposures, including serum, anthropometric measures and dietary assessments, we will examine: (1) whether dietary factors that affect each postulated mechanism are associated with risk of prostate cancer and (2) whether the effects of finasteride on prostate cancer risk are modified by diet and diet-related factors. In collaboration with Project 4, we propose to examine associations of dietary and phospholipid fatty acids with the extent, degree and characteristics of inflammation and atrophy in prostate tissue biopsies. Further collaborations are specified in the aims of all other P01 projects, examining risk of prostate cancer as a function of joint associations between: (a) steroid hormones and obesity; (b) obesity and insulin resistance; (c) dairy products and IGFs; (d) antioxidants and inflammation; and (e) antioxidants and polymorphisms in oxidative stress genes. The primary endpoint for all analyses will be the presence or absence of biopsy-detected prostate cancer, which will be characterized either as total cancer or as low- and high-grade disease {Gleason score 2-6 vs. 7-10). Using a nested case-control design, we will have 80% power to detect a minimum odds ratio for total prostate cancer of 1.29 and 1.6 for high-grade disease of 1.86, contrasting highest to lowest quartiles of dietary exposures. This study will yield substantial new information about the relationships of diet with the development of prostate cancer. It may also help to identify diet-related characteristics that could be used to select persons most likely to benefit from finasteride treatment, or to identify dietary
modifications or supplements that could be used as adjunct treatment to increase finasteride efficacy.
描述(由申请人提供):这项修订后的研究建议检查广泛的
饮食和饮食相关的生活方式因素影响前列腺癌的风险,并围绕两种机制进行组织:类固醇激素、胰岛素和胰岛素样生长因子刺激细胞生长;以及氧化损伤导致的体细胞突变积累。这项修订提案中的重大修改包括更详细和假设驱动的交叉项目目标,更准确的样本量估计,以及关于肥胖和血糖指数的初步研究的完成。利用PCPT关于饮食相关暴露的综合数据,包括血清、人体测量和饮食评估,我们将检查:(1)影响每个假设机制的饮食因素是否与前列腺癌风险相关,以及(2)非那雄胺对前列腺癌风险的影响是否被饮食和饮食相关因素改变。在与项目4的合作中,我们建议检查饮食和磷脂脂肪酸与前列腺组织活检中炎症和萎缩的程度、程度和特征的相关性。在所有其他P01项目的目标中明确了进一步的合作,研究前列腺癌的风险是下列因素共同作用的结果:(A)类固醇激素与肥胖症;(B)肥胖症与胰岛素抵抗;(C)乳制品与IGF;(D)抗氧化剂与炎症;(E)抗氧化剂和氧化应激基因的多态。所有分析的主要终点将是活检检测到的前列腺癌的存在或不存在,这将被描述为完全癌症或低级别和高级别疾病(Gleason评分2-6比7-10)。使用嵌套病例对照设计,我们将有80%的能力检测总前列腺癌的最小优势比为1.29,高级别疾病的最小优势比为1.86,对比饮食暴露的最高和最低四分位数。这项研究将提供大量关于饮食与前列腺癌发病关系的新信息。它还可能有助于确定与饮食有关的特征,这些特征可用于选择最有可能从非那雄胺治疗中受益的人,或用于确定饮食
可作为辅助治疗以增加非那雄胺疗效的修饰或补充。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT M LIPPMAN其他文献
SCOTT M LIPPMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT M LIPPMAN', 18)}}的其他基金
Biology of the Prostate Cancer Prevention Trial (PCPT)
前列腺癌预防试验 (PCPT) 的生物学
- 批准号:
6907173 - 财政年份:2005
- 资助金额:
$ 25.75万 - 项目类别:
Biology of the Prostate Cancer Prevention Trial (PCPT)
前列腺癌预防试验 (PCPT) 的生物学
- 批准号:
7418582 - 财政年份:2005
- 资助金额:
$ 25.75万 - 项目类别:
IGF-1Axis and Insulin Resistance in PCPT
PCPT 中的 IGF-1 轴和胰岛素抵抗
- 批准号:
7102930 - 财政年份:2005
- 资助金额:
$ 25.75万 - 项目类别:
Genotypic and Phenotypic Studies of Inflammation in PCPT
PCPT 炎症的基因型和表型研究
- 批准号:
7102931 - 财政年份:2005
- 资助金额:
$ 25.75万 - 项目类别:
Biology of the Prostate Cancer Prevention Trial (PCPT)
前列腺癌预防试验 (PCPT) 的生物学
- 批准号:
7059466 - 财政年份:2005
- 资助金额:
$ 25.75万 - 项目类别:
相似海外基金
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10829054 - 财政年份:2023
- 资助金额:
$ 25.75万 - 项目类别:
Utilization of cervical cancer prevention tools and role of high-risk HPV type in the persistent cervical cancer disparities experienced by American Indian/Alaska Native women
宫颈癌预防工具的利用以及高危 HPV 类型在美洲印第安人/阿拉斯加原住民妇女经历的持续性宫颈癌差异中的作用
- 批准号:
10452479 - 财政年份:2021
- 资助金额:
$ 25.75万 - 项目类别:
Utilization of cervical cancer prevention tools and role of high-risk HPV type in the persistent cervical cancer disparities experienced by American Indian/Alaska Native women
宫颈癌预防工具的利用以及高危 HPV 类型在美洲印第安人/阿拉斯加原住民妇女经历的持续性宫颈癌差异中的作用
- 批准号:
10674523 - 财政年份:2021
- 资助金额:
$ 25.75万 - 项目类别:
Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America
拉丁美洲资源匮乏地区预防宫颈癌的精准甲基化生物标志物
- 批准号:
10258144 - 财政年份:2021
- 资助金额:
$ 25.75万 - 项目类别:
Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America
拉丁美洲资源匮乏地区预防宫颈癌的精准甲基化生物标志物
- 批准号:
10654910 - 财政年份:2021
- 资助金额:
$ 25.75万 - 项目类别:
Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America
拉丁美洲资源匮乏地区预防宫颈癌的精准甲基化生物标志物
- 批准号:
10666709 - 财政年份:2021
- 资助金额:
$ 25.75万 - 项目类别:
Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia
生物标志物可提高非典型增生女性乳腺癌预防的针对性
- 批准号:
10542756 - 财政年份:2020
- 资助金额:
$ 25.75万 - 项目类别: